
USA - New York Stock Exchange - NYSE:DPLO -
ChartMill assigns a fundamental rating of 1 / 10 to DPLO.
ChartMill assigns a valuation rating of 1 / 10 to DIPLOMAT PHARMACY INC (DPLO). This can be considered as Overvalued.
DIPLOMAT PHARMACY INC (DPLO) has a profitability rating of 1 / 10.
The Earnings per Share (EPS) of DIPLOMAT PHARMACY INC (DPLO) is expected to decline by -560% in the next year.